Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc.Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
